George Yancopoulos, EVP CSO President Regeneron Re at REGENERON PHARMACEUTICALS INC (REGN), sold 171,105 shares at $59.45 ($10.0M) on 2011-12-01, disclosed to the SEC on 2011-12-02.
Scheduled sale ($10.0M) by EVP CSO President Regeneron Re under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 670 | $0 | 0.0% |
| 2 | $58.19 | 1,718 | $100K | 1.0% |
| 3 | $58.19 | 46,453 | $2.7M | 27.2% |
| 4 | $58.19 | 94,551 | $5.5M | 55.3% |
| 5 | $58.86 | 3,300 | $194K | 2.0% |
| 6 | $59.45 | 24,413 |
| $1.5M |
| 14.6% |
| Total | $58.15 avg | 171,105 | $10.0M | 100% |
| Filing → |
| REGN | SELL | 2024-01-04 | $15.2M | — | Filing → |
| REGN | SELL | 2023-03-27 | $5.0M | — | Filing → |
| REGN | SELL | 2023-02-08 | $21.1M | — | Filing → |